• Crestor
• Banned
• Cardiomyopathy
• Cases
• Cholesterol
• Class Action
• Concerns
• Dangers
• Deaths
• Heart Failure
• Heart Failure Lawsuit
• Heart Failure Lawyer
• Heart Problems
• Kidney Failure
• Kidney Pain
• Lawsuit
• Leg Pain
• Liver Damage
• Liver Failure
• Medication
• Muscle Damage
• Muscle Pain
• News
• Patient Information
• Problem
• Recall
• Renal Failure
• Rhabdomyolysis
• Risk
• Safety
• Side Effects
• Statin Drug
• Warning
• Weight Loss
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

The Crestor problem involves the serious adverse health problems that are associated with taking Crestor. Manufactured by AstraZeneca and approved for use in August of 2003, Crestor is touted as a “super satin” that effectively lowers cholesterol levels and reduces a patient''s risk of heart complications. Crestor has been aggressively marketed by its makers in its first year on the market, despite several Crestor problem reports that show serious health consequences for people taking this medication.

Crestor''s cohort, Baycol (manufactured by Bayer) was recalled in 2001 when serious health risks associated with taking this product outweighed its potential benefits. This drug closely resembles Crestor in form and function. Baycol was pulled from the market when it was discovered that Baycol use increases a patient''s risks of developing serious kidney and muscle diseases.

Indications of Crestor problem side effects appeared long before this drug was even approved for use by the Federal Drug Administration. Patients taking higher doses of this drug developed serious cases of Crestor problem symptoms including those of degenerative muscle disease and liver and kidney failure. Because of these Crestor problem findings, Crestor was not approved for use at higher doses (80 milligrams).

The makers of Crestor have already acknowledged two of Crestor problem areas associated with its use. People with a history of liver problems are urged not to take Crestor because it is associated with biochemical abnormalities in liver function. Patients, informed of this Crestor problem, are advised to have their liver function frequently tested and monitored while taking Crestor. Another serious Crestor problem is its effects on pregnant women. Women who are pregnant, or plan to become pregnant, should not take Crestor because it can cause birth defects in a developing fetus.

One of the most serious Crestor problem reports involves its association with the potentially fatal muscle disease known as rhabdomyolysis. Rhabdomyolysis destroys muscle tissue and causes the excretion of myoglobin and potassium into the blood stream. When these chemicals enter the bloodstream the volume of blood circulating in the body is stifled. This Crestor problem can lead to acute kidney failure, where the kidneys are no longer able to properly excrete waste and maintain proper electrolyte balance. This Crestor problem can lead to serious disability or death.

Symptoms of this serious Crestor problem should be evaluated by medical professionals at the first sign of complication. Symptoms of a serious Crestor problem can include nausea and vomiting, stomach pain, weakness or tenderness, fever, dark urine, and malaise.

If you or a loved one is taking Crestor for high cholesterol, it is important to be aware of the many Crestor problem risks that are associated with taking this medication. If you have been injured as a result of a serious Crestor problem, you may be eligible to seek compensation for your suffering though a Crestor lawsuit.

"Possible Crestor®-Heart Failure Link"

Some researchers believe the cholesterol medication Crestor® (rosuvastatin) can increase the severity of heart failure in certain patients.

Coenzyme Q10 (CoQ10), pro...

» Read More

"FDA rejects petition to ban Crestor"

The consumer advocacy group Public Citizen submitted a petition to the FDA a year ago asking the agency to immediately withdraw the anti-cholesterol drug Crestor, but the agency has denied its request.

Crestor belongs to a group of drugs ...

» Read More

"Asians taking Crestor may be at higher risk for rhabdomyolysis"

The FDA has announced that Crestor is being relabeled to add a warning that starter doses should be reduced in Asian-American patients, as well as some other higher risk patients.

A clinical trial found that levels in Asian patients were d...

» Read More